Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1395


Crossover study in hyperammonemia patients for efficacy, safety, and acceptability of a new lactulose preparation (SK-1202) compared to approved drug.

Yoshiji H, Karino Y, Suzuki Y, Suzuki F, Uejima M, Aikata H, Chayama K, Iwai H, Suzuki E, Kumada H.

Hepatol Res. 2018 Jul 13. doi: 10.1111/hepr.13228. [Epub ahead of print]


Bacterial Memory of Persisters: Bacterial Persister Cells Can Retain Their Phenotype for Days or Weeks After Withdrawal From Colony-Biofilm Culture.

Miyaue S, Suzuki E, Komiyama Y, Kondo Y, Morikawa M, Maeda S.

Front Microbiol. 2018 Jun 26;9:1396. doi: 10.3389/fmicb.2018.01396. eCollection 2018.


Five Cases of Interstitial Pneumonitis Due to Gemcitabine and Nab-Paclitaxel Combination Treatment in Pancreatic Cancer Patients.

Ogawa Y, Suzuki E, Mikata R, Yasui S, Abe M, Iino Y, Ohyama H, Chiba T, Tsuyuguchi T, Kato N.

Pancreas. 2018 Aug;47(7):e42-e43. doi: 10.1097/MPA.0000000000001088. No abstract available.


Neutrophils Kill Antibody-Opsonized Cancer Cells by Trogoptosis.

Matlung HL, Babes L, Zhao XW, van Houdt M, Treffers LW, van Rees DJ, Franke K, Schornagel K, Verkuijlen P, Janssen H, Halonen P, Lieftink C, Beijersbergen RL, Leusen JHW, Boelens JJ, Kuhnle I, van der Werff Ten Bosch J, Seeger K, Rutella S, Pagliara D, Matozaki T, Suzuki E, Menke-van der Houven van Oordt CW, van Bruggen R, Roos D, van Lier RAW, Kuijpers TW, Kubes P, van den Berg TK.

Cell Rep. 2018 Jun 26;23(13):3946-3959.e6. doi: 10.1016/j.celrep.2018.05.082.


Methotrexate-associated lymphoproliferative disorder complicated by severe acute respiratory failure and ileal perforation: a case report.

Suzuki E, Kanno T, Kimura S, Irie T, Odajima H, Migita K.

Fukushima J Med Sci. 2018 Jun 19. doi: 10.5387/fms.2017-23. [Epub ahead of print]


Agreement between patients' and radiation oncologists' cancer diagnosis and prognosis perceptions: A cross sectional study in Japan.

Mackenzie LJ, Carey ML, Suzuki E, Sanson-Fisher RW, Asada H, Ogura M, D'Este C, Yoshimura M, Toi M.

PLoS One. 2018 Jun 8;13(6):e0198437. doi: 10.1371/journal.pone.0198437. eCollection 2018.


A Novel Mutation in NKX2.1 Shows Dominant-Negative Effects Only in the Presence of PAX8.

Shinohara H, Takagi M, Ito K, Suzuki E, Fukuzawa R, Hasegawa T.

Thyroid. 2018 Jun 8. doi: 10.1089/thy.2017.0481. [Epub ahead of print]


Long-term events after physician-referred initial tests by myocardial perfusion imaging or computed tomography coronary angiography in patients with suspected coronary artery disease.

Naya M, Uemura Y, Matsumoto N, Momose M, Kato T, Hida S, Yamauchi T, Nakajima T, Suzuki E, Tamaki N; J-COMPASS Extended Follow-Up Study Group.

Coron Artery Dis. 2018 Jun 5. doi: 10.1097/MCA.0000000000000645. [Epub ahead of print]


Development of PCR for identifying Streptococcus parasuis, a close relative of Streptococcus suis.

Yamada R, Tien LHT, Arai S, Tohya M, Ishida-Kuroki K, Nomoto R, Kim H, Suzuki E, Osawa R, Watanabe T, Sekizaki T.

J Vet Med Sci. 2018 Jul 12;80(7):1101-1107. doi: 10.1292/jvms.18-0083. Epub 2018 Jun 6.


Multicenter retrospective analysis of systemic chemotherapy for unresectable combined hepatocellular and cholangiocarcinoma.

Kobayashi S, Terashima T, Shiba S, Yoshida Y, Yamada I, Iwadou S, Horiguchi S, Takahashi H, Suzuki E, Moriguchi M, Tsuji K, Otsuka T, Asagi A, Kojima Y, Takada R, Morizane C, Mizuno N, Ikeda M, Ueno M, Furuse J.

Cancer Sci. 2018 Jun 1. doi: 10.1111/cas.13656. [Epub ahead of print]


Left gastric vein-based noninvasive test for esophageal varices: a same-day comparison of portal hemodynamic assessment with endoscopic appearance.

Maruyama H, Kobayashi K, Kiyono S, Ogasawara S, Ooka Y, Suzuki E, Chiba T, Kato N.

Clin Transl Gastroenterol. 2018 May 25;9(5):154. doi: 10.1038/s41424-018-0021-8.


Adding colchicine to immunosuppressive treatments; a potential option for biologics-refractory adult-onset Still's disease.

Asano T, Furuya MY, Sato S, Kobayashi H, Watanabe H, Suzuki E, Migita K.

BMC Res Notes. 2018 May 21;11(1):320. doi: 10.1186/s13104-018-3420-8.


Transarterial chemoembolization as a substitute to radiofrequency ablation for treating Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma.

Ishikawa K, Chiba T, Ooka Y, Suzuki E, Ogasawara S, Maeda T, Yokoyama M, Inoue M, Wakamatsu T, Kusakabe Y, Saito T, Tawada A, Arai M, Kanda T, Maruyama H, Imazeki F, Kato N.

Oncotarget. 2018 Apr 20;9(30):21560-21568. doi: 10.18632/oncotarget.25108. eCollection 2018 Apr 20.


Allergy to chlorpromazine and valproic acid following carbamazepine hypersensitivity in a patient with an HLA-B*4601 allele.

Sakurada K, Kozaru T, Yamada K, Nibuya M, Nagata K, Suzuki E.

Neuropsychiatr Dis Treat. 2018 May 4;14:1139-1142. doi: 10.2147/NDT.S162261. eCollection 2018.


[Outcome of Surgical Treatment of Locally Advanced Lung Cancer after Induction Chemoradiotherapy].

Tanahashi M, Yukiue H, Suzuki E, Yoshii N, Kitazawa S, Kaminuma Y, Niwa H.

Kyobu Geka. 2018 Apr;71(4):278-283. Japanese.


Real-time navigation system for sentinel lymph node biopsy in breast cancer patients using projection mapping with indocyanine green fluorescence.

Takada M, Takeuchi M, Suzuki E, Sato F, Matsumoto Y, Torii M, Kawaguchi-Sakita N, Nishino H, Seo S, Hatano E, Toi M.

Breast Cancer. 2018 May 9. doi: 10.1007/s12282-018-0868-2. [Epub ahead of print]


Mechanisms and uncertainty in randomized controlled trials: A commentary on Deaton and Cartwright.

Suzuki E, VanderWeele TJ.

Soc Sci Med. 2018 Apr 18. pii: S0277-9536(18)30190-4. doi: 10.1016/j.socscimed.2018.04.023. [Epub ahead of print] No abstract available.


A cross-sectional study of agreement between the Hospital Anxiety and Depression Scale and patient- and radiation oncologist-reported single-item assessment of depression and anxiety.

Mackenzie L, Carey M, Suzuki E, Yoshimura M, Toi M, D'Este C, Sanson-Fisher R.

Psychooncology. 2018 Jul;27(7):1840-1846. doi: 10.1002/pon.4736. Epub 2018 May 16.


Successful retreatment with grazoprevir and elbasvir for patients infected with hepatitis C virus genotype 1b, who discontinued prior treatment with NS5A inhibitor-including regimens due to adverse events.

Kanda T, Yasui S, Nakamura M, Nakamoto S, Takahashi K, Wu S, Sasaki R, Haga Y, Ogasawara S, Saito T, Kobayashi K, Kiyono S, Ooka Y, Suzuki E, Chiba T, Maruyama H, Moriyama M, Kato N.

Oncotarget. 2018 Mar 23;9(22):16263-16270. doi: 10.18632/oncotarget.24620. eCollection 2018 Mar 23.


Interferon-free treatment for patients with chronic hepatitis C and autoimmune liver disease: higher SVR rates with special precautions for deterioration of autoimmune hepatitis.

Kanda T, Yasui S, Nakamura M, Nakamoto S, Takahashi K, Wu S, Sasaki R, Haga Y, Ogasawara S, Saito T, Kobayashi K, Kiyono S, Ooka Y, Suzuki E, Chiba T, Maruyama H, Imazeki F, Moriyama M, Kato N.

Oncotarget. 2018 Feb 3;9(14):11631-11637. doi: 10.18632/oncotarget.24391. eCollection 2018 Feb 20.

Supplemental Content

Loading ...
Support Center